Complex karyotype in patients with mantle cell lymphoma predicts inferior survival and poor response to intensive induction therapy-Reference-Cited by-同舟云学术

Complex karyotype in patients with mantle cell lymphoma predicts inferior survival and poor response to intensive induction therapy

Published:2018-03-26 Issue:11 Volume:124 Page:2306-2315
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Greenwell I. Brian¹^ORCID,Staton Ashley D.¹,Lee Michael J.¹,Switchenko Jeffrey M.¹,Saxe Debra F.¹,Maly Joseph J.²,Blum Kristie A.²,Grover Natalie S.³,Mathews Stephanie P.⁴,Gordon Max J.⁵,Danilov Alexey V.⁵,Epperla Narendranath⁶^ORCID,Fenske Timothy S.⁶,Hamadani Mehdi⁶^ORCID,Park Steven I.⁷,Flowers Christopher R.¹^ORCID,Cohen Jonathon B.¹

Affiliation:

1. Department of Hematology and Medical Oncology, Winship Cancer Institute; Emory University; Atlanta Georgia

2. Division of Hematology/Oncology; The Ohio State University James Cancer Hospital; Columbus Ohio

3. Division of Hematology/Oncology; University of North Carolina at Chapel Hill Lineberger Cancer Center; Chapel Hill North Carolina

4. Department of Pathology and Laboratory Medicine; University of North Carolina at Chapel Hill Lineberger Cancer Center; Chapel Hill North Carolina

5. Department of Medicine, OHSU Knight Cancer Institute; Portland Oregon

6. Department of Hematology and Oncology, Medical College of Wisconsin Cancer Center; Milwaukee Wisconsin

7. Levine Cancer Institute; Charlotte North Carolina

Funder

Winship Cancer Institute of Emory University

National Institutes of Health

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference20 articles.

1. Deferred therapy is associated with improved overall survival in patients with newly diagnosed mantle cell lymphoma;Cohen;Cancer.,2016

2. Outcome of deferred initial therapy in mantle-cell lymphoma;Martin;J Clin Oncol.,2009

3. A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma;Hoster;Blood.,2008

4. Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network;Hoster;J Clin Oncol.,2014

5. Mantle cell lymphoma international prognostic index but not pretransplantation induction regimen predicts survival for patients with mantle-cell lymphoma receiving high-dose therapy and autologous stem-cell transplantation;Budde;J Clin Oncol.,2011

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SOHO State of the Art Updates and Next Questions: Treatment Evolution of Mantle Cell Lymphoma: Navigating the Different Entities and Biological Heterogeneity of Mantle Cell Lymphoma in 2024;Clinical Lymphoma Myeloma and Leukemia;2024-08

2. Biological and clinical determinants shaping heterogeneity in mantle cell lymphoma;BLOOD ADV;2024

3. Biological and clinical determinants shaping heterogeneity in mantle cell lymphoma;Blood Advances;2024-07-11

4. Molecular Pathology of Mature Lymphoid Malignancies;Clinics in Laboratory Medicine;2024-06

5. MYCT1 inhibits hematopoiesis in diffuse large B-cell lymphoma by suppressing RUNX1 transcription;Cellular & Molecular Biology Letters;2024-01-03